Adjuvant immunotherapy in the modern management of resectable melanoma: current status and outlook to 2028

Donia, M.; Jespersen, H.; Jalving, M.; Lee, R.; Eriksson, H.; Hoeller, C.; Hernberg, M.; Gavrilova, I.; Kandolf, L.; Liszkay, G.; Helgadottir, H.; Zhukavets, A.; Pianova, D.; Marquez-Rodas, I.; Neyns, B.; Westgeest, H.; Pourmir, I.; Sobczuk, P.; Ellebaek, E.; Amaral, T.

dc.contributor.author	Amaral, Teresa
dc.date.accessioned	2025-11-18T09:58:08Z
dc.date.available	2025-11-18T09:58:08Z
dc.date.issued	2025
dc.identifier.issn	2059-7029
dc.identifier.uri	http://hdl.handle.net/10900/172326
dc.language.iso	en	de_DE
dc.publisher	Amsterdam : Elsevier	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/j.esmoop.2025.104295	de_DE
dc.subject.ddc	610	de_DE
dc.title	Adjuvant immunotherapy in the modern management of resectable melanoma: current status and outlook to 2028	de_DE
dc.type	Article	de_DE
utue.quellen.id	20250630000000_01446
utue.personen.roh	Donia, M.
utue.personen.roh	Jespersen, H.
utue.personen.roh	Jalving, M.
utue.personen.roh	Lee, R.
utue.personen.roh	Eriksson, H.
utue.personen.roh	Hoeller, C.
utue.personen.roh	Hernberg, M.
utue.personen.roh	Gavrilova, I.
utue.personen.roh	Kandolf, L.
utue.personen.roh	Liszkay, G.
utue.personen.roh	Helgadottir, H.
utue.personen.roh	Zhukavets, A.
utue.personen.roh	Pianova, D.
utue.personen.roh	Marquez-Rodas, I.
utue.personen.roh	Neyns, B.
utue.personen.roh	Westgeest, H.
utue.personen.roh	Pourmir, I.
utue.personen.roh	Sobczuk, P.
utue.personen.roh	Ellebaek, E.
utue.personen.roh	Amaral, T.
dcterms.isPartOf.ZSTitelID	Esmo Open	de_DE
dcterms.isPartOf.ZS-Issue	Article 104295	de_DE
dcterms.isPartOf.ZS-Volume	10 (3)	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE